Literature DB >> 12110799

Surgical management of intraductal papillary mucinous tumor of the pancreas.

Ryuichiro Doi1, Koji Fujimoto, Michihiko Wada, Masayuki Imamura.   

Abstract

BACKGROUND: Intraductal papillary mucinous tumor (IPMT) is a type of pancreatic cystic neoplasm. IPMT consists of intraductal papillary mucinous adenoma (benign IPMT) and intraductal papillary mucinous carcinoma (malignant IPMT). Preoperative diagnosis of malignancy is difficult; the invasiveness and metastatic character are not well known. The purpose of the study was to evaluate the optimal diagnostic and therapeutic strategy of IPMT.
METHODS: Medical charts of 38 patients with final diagnosis of IPMT in Kyoto University Hospital were retrospectively reviewed. Preoperative imaging, mode of operation, and clinical and histopathologic findings were analyzed.
RESULTS: In 38 IPMTs, imaging of localization was correct in 82% by computed tomography, 90% by ultrasonography, 70% by endoscopic retrograde cholangiopancreatography, 100% by magnetic resonance cholangiopancreatography, and 100% by endoscopic ultrasonography. Evaluation of malignancy by endoscopic ultrasonography resulted in sensitivity and specificity of 81% and 78%, respectively. Pylorus-preserving pancreaticoduodenectomy was preferably performed in 20 of 38 patients with IPMT. Twenty-two patients had histologically malignant disease. Half of them had an invasive component in the adjacent stroma. One case of malignant IPMT showed lymph node metastasis, and the patient had no recurrence after pancreaticoduodenectomy with regional lymphadenectomy. No case was diagnosed as margin positive; however, 27% showed a dysplasia with atypia in the epithelial cells of the cut edge of the pancreas. One patient with negative atypia at the cut edge of the pancreas developed a recurrent tumor in the remnant pancreas.
CONCLUSIONS: The preoperative diagnosis of malignancy is difficult, and 50% of malignant IPMT showed an invasive component. Thus, radical resection of the pancreas with regional lymph node dissection should be the choice of treatment. Lymph node metastasis and intraductal distant invasion should be carefully managed in the surgical treatment of these lesions.

Entities:  

Mesh:

Year:  2002        PMID: 12110799     DOI: 10.1067/msy.2002.125386

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  39 in total

1.  Intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Jose G Trevino; N Joseph Espat; W Scott Helton
Journal:  Curr Treat Options Gastroenterol       Date:  2006-09

Review 2.  Ultrasonographic findings and natural history of intraductal papillary-mucinous neoplasms of the pancreas.

Authors:  Go Kobayashi; Naotaka Fujita; Yutaka Noda; Takashi Obana; Osamu Takasawa
Journal:  J Med Ultrason (2001)       Date:  2008-09-19       Impact factor: 1.314

3.  Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Atsushi Kanno; Kennichi Satoh; Morihisa Hirota; Shin Hamada; Jun Umino; Hiromichi Itoh; Atsushi Masamune; Tohru Asakura; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2010-04-10       Impact factor: 7.527

Review 4.  Precursors to pancreatic cancer.

Authors:  Ralph H Hruban; Anirban Maitra; Scott E Kern; Michael Goggins
Journal:  Gastroenterol Clin North Am       Date:  2007-12       Impact factor: 3.806

5.  Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.

Authors:  Roberto Salvia; Carlos Fernández-del Castillo; Claudio Bassi; Sarah P Thayer; Massimo Falconi; William Mantovani; Paolo Pederzoli; Andrew L Warshaw
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

6.  Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experience.

Authors:  Marco Niedergethmann; Robert Grützmann; Ralf Hildenbrand; Dag Dittert; Niloufar Aramin; Melanie Franz; Frank Dobrowolski; Stefan Post; Hans-Detlev Saeger
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

7.  Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis.

Authors:  Edward S Huang; G Scott Gazelle; Chin Hur
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

Review 8.  Management of mucin-producing cystic neoplasms of the pancreas.

Authors:  Stefan Fritz; Andrew L Warshaw; Sarah P Thayer
Journal:  Oncologist       Date:  2009-02-11

9.  Intraductal papillary mucinous neoplasm of the pancreas (IPMN): clinico-pathological correlations and surgical indications.

Authors:  Gian Luca Baiocchi; Nazario Portolani; Guido Missale; Carla Baronchelli; Federico Gheza; Massimiliano Cantù; Luigi Grazioli; Stefano M Giulini
Journal:  World J Surg Oncol       Date:  2010-04-07       Impact factor: 2.754

10.  Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Yasuo Hayashidani; Takeshi Sudo; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.